Theratechnologies to Present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021
Theratechnologies (TSX: TH, NASDAQ: THTX), a biopharmaceutical company, announced that CEO Paul Levesque will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, at 9:40 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (TSX: TH, NASDAQ: THTX), a biopharmaceutical company, announced that CEO Paul Levesque will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021, at 9:40 a.m. ET. Investors can access a live webcast through the investor relations section of Theratechnologies’ website or via a direct link to the virtual conference. An archive of the presentation will be available for 90 days post-event. Theratechnologies focuses on developing innovative therapies for unmet medical needs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will present at the Credit Suisse 30th Annual Healthcare Conference on November 11, 2021 at 9:40 a.m. ET.
A live webcast of the event can be accessed through the investor relations section of Theratechnologies’ website under ‘Events’ or via the virtual conference link. An archive will also be available for 90 days following the event.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
438-315-6608
communications@theratech.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.